Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (domestic) or 706-634-5454 (international) and referencing conference ID number 22672003. The call will also be broadcast live on the internet on the Company's website at www.insmed.com.
A replay of the conference call will be accessible two hours after its completion through
This release contains forward-looking statements. Words, and variations of words, such as "intend," "expect," "will," "anticipate," "believe," "continue," "propose" and similar expressions are intended to identify forward-looking statements. Investors are cautioned that such statements in this release, including statements relating to the status, results and timing of clinical trials and clinical data, the anticipated benefits of Insmed's products, the anticipated timing of regulatory submissions, and the ability to obtain required regulatory approvals, bring products to market and successfully commercialize products constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, without limitation, failure or delay of European, Canadian,